Ultragenyx Pharmaceutical (RARE) Q2 2017 Earnings

4MayConfirmed
Aug 16
Q4 2016
Q1 2017
Q2 2017
-1.75
-1.65
-1.54
-1.44

Details

Expected EPS
-1.69
Actual EPS
-1.63
Surprise EPS
0.06
Surprise Percent
+3.55%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.63 per share for Q2 2017.

0 Comments

Share your thoughts